Loading
Utrecht haematologist and immunotherapy researcher on the daily board of UMC Utrecht's cancer programme, known for gamma-delta T cell receptor-engineered cell therapies.
Jürgen Kuball is Professor of Haematology at UMC Utrecht and a member of the Daily Board of its Strategic Program Cancer. He leads the haematology department and a translational research group developing gamma-delta T cell receptor-based cellular immunotherapies for haematological and solid cancers. His work spans allogeneic stem cell transplantation and engineered T cell products.
Shares Haematologica, Acute myeloid leukaemia, Multiple myeloma and the tags leadership, clinician-scientist, haematology.
Shares Acute myeloid leukaemia, Multiple myeloma and the tags leadership, clinician-scientist, haematology.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.